Pan and colleagues [107] were the first to establish that treatment with Nec-1 or RIPK3 deficiency attenuated the hypothermia symptom, a systemic inflammatory response by decreasing neutrophil infiltration, and increased the survival rate of oleic acid-fed rat, which acts as a model of ARDS. Here, RIPK3 is linked to acute respiratory distress syndrome.